TNGXTango Therapeutics, Inc.
- Market cap
- $3.94B
- as of 2026-10-23
- Latest close
- $23.34
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-11
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Crystal AdamPresident, R&D | Oct 1 | Oct 5 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Oct 1 | Oct 5 | S | 26,400 | $24.45 | Sale −$645,604 | 116,343 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Oct 1 | Oct 5 | S | 600 | $25.32 | Sale −$15,192 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Oct 1 | Oct 5 | M · derivative | 27,000 | $5.20 | $140,400 | 233,040 | Yes | Form 4 |
| Newcomb JessicaPrincipal Accounting Officer | Sep 22 | Sep 24 | S | 700 | $22.80 | Sale −$15,960 | 66,621 | Yes | Form 4 |
| Newcomb JessicaPrincipal Accounting Officer | Sep 22 | Sep 24 | S | 5,100 | $23.97 | Sale −$122,247 | 61,521 | Yes | Form 4 |
| Newcomb JessicaPrincipal Accounting Officer | Sep 22 | Sep 24 | S | 2,400 | $25.17 | Sale −$60,408 | 59,121 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Sep 1 | Sep 3 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Sep 1 | Sep 3 | S | 27,000 | $22.37 | Sale −$603,990 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Sep 1 | Sep 3 | M · derivative | 27,000 | $5.20 | $140,400 | 260,040 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Aug 3 | Aug 5 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Aug 3 | Aug 5 | S | 5,267 | $26.79 | Sale −$141,103 | 137,476 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Aug 3 | Aug 5 | S | 21,733 | $27.35 | Sale −$594,398 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Aug 3 | Aug 5 | M · derivative | 27,000 | $5.20 | $140,400 | 287,040 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jul 1 | Jul 2 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jul 1 | Jul 2 | S | 19,629 | $29.34 | Sale −$575,915 | 123,114 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jul 1 | Jul 2 | S | 7,371 | $30.25 | Sale −$222,973 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jul 1 | Jul 2 | M · derivative | 27,000 | $5.20 | $140,400 | 314,040 | Yes | Form 4 |
| Azelby Robert | Jun 19 | Jun 23 | A | 5,740 | $0.00 | $0 | 5,740 | No | Form 4 |
| Azelby Robert | Jun 19 | Jun 23 | A · derivative | 35,910 | $27.97 | $1,004,403 | 35,910 | No | Form 4 |
| Lee Sung | Jun 5 | Jun 8 | A | 570 | $0.00 | $0 | 22,870 | No | Form 4 |
| Lee Sung | Jun 5 | Jun 8 | A · derivative | 3,570 | $20.22 | $72,185 | 3,570 | No | Form 4 |
| Rothenberg Mace | Jun 5 | Jun 8 | A | 4,000 | $0.00 | $0 | 41,500 | No | Form 4 |
| Rothenberg Mace | Jun 5 | Jun 8 | A · derivative | 25,000 | $20.22 | $505,500 | 25,000 | No | Form 4 |
| Calhoun Lesley Ann | Jun 5 | Jun 8 | A | 4,000 | $0.00 | $0 | 16,500 | No | Form 4 |
| Calhoun Lesley Ann | Jun 5 | Jun 8 | A · derivative | 25,000 | $20.22 | $505,500 | 25,000 | No | Form 4 |
| Ketchum John B | Jun 5 | Jun 8 | A | 4,000 | $0.00 | $0 | 24,937 | No | Form 4 |
| Ketchum John B | Jun 5 | Jun 8 | A · derivative | 25,000 | $20.22 | $505,500 | 25,000 | No | Form 4 |
| Crystal AdamPresident, R&D | Jun 1 | Jun 3 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jun 1 | Jun 3 | S | 6,140 | $22.25 | Sale −$136,615 | 136,603 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jun 1 | Jun 3 | S | 20,860 | $23.06 | Sale −$481,032 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Jun 1 | Jun 3 | M · derivative | 27,000 | $5.20 | $140,400 | 341,040 | Yes | Form 4 |
| Gall MatthewChief Financial Officer | May 1 | May 5 | A | 40,000 | $0.00 | $0 | 40,000 | No | Form 4 |
| Gall MatthewChief Financial Officer | May 1 | May 5 | A · derivative | 240,000 | $20.98 | $5,035,200 | 240,000 | No | Form 4 |
| Crystal AdamPresident, R&D | May 1 | May 5 | M | 27,000 | $5.20 | $140,400 | 142,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | May 1 | May 5 | S | 25,900 | $21.19 | Sale −$548,821 | 116,843 | Yes | Form 4 |
| Crystal AdamPresident, R&D | May 1 | May 5 | S | 1,100 | $22.00 | Sale −$24,200 | 115,743 | Yes | Form 4 |
| Crystal AdamPresident, R&D | May 1 | May 5 | M · derivative | 27,000 | $5.20 | $140,400 | 368,040 | Yes | Form 4 |
| Lee Sung | Apr 29 | May 1 | A | 12,300 | $0.00 | $0 | 22,300 | No | Form 4 |
| Lee Sung | Apr 29 | May 1 | A · derivative | 5,200 | $22.06 | $114,712 | 5,200 | No | Form 4 |
| Crystal AdamPresident, R&D | Apr 15 | Apr 16 | M | 38,460 | $5.20 | $199,992 | 151,082 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Apr 15 | Apr 16 | S | 38,460 | $25.00 | Sale −$961,500 | 112,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Apr 15 | Apr 16 | M · derivative | 38,460 | $5.20 | $199,992 | 395,040 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Apr 1 | Apr 2 | M | 27,000 | $5.20 | $140,400 | 139,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Apr 1 | Apr 2 | S | 27,000 | $21.20 | Sale −$572,400 | 112,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Apr 1 | Apr 2 | M · derivative | 27,000 | $5.20 | $140,400 | 433,500 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Mar 25 | Mar 27 | M | 12,000 | $5.20 | $62,400 | 124,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Mar 25 | Mar 27 | S | 12,000 | $20.11 | Sale −$241,320 | 112,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Mar 25 | Mar 27 | M · derivative | 12,000 | $5.20 | $62,400 | 460,500 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Mar 5 | Mar 9 | S | 20,251 | $15.00 | Sale −$303,765 | 112,622 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Feb 25 | Feb 27 | S | 54,345 | $12.77 | Sale −$693,986 | 132,873 | Yes | Form 4 |
| Crystal AdamPresident, R&D | Feb 3 | Feb 4 | S | 18,251 | $12.26 | Sale −$223,757 | 187,419 | No | Form 4 |
| Crystal AdamPresident, R&D | Feb 3 | Feb 4 | S | 201 | $12.90 | Sale −$2,593 | 187,218 | No | Form 4 |
| Weber BarbaraDirector, Executive Chair | Feb 3 | Feb 4 | S | 30,186 | $12.26 | Sale −$370,080 | 1,629,587 | No | Form 4 |
| Weber BarbaraDirector, Executive Chair | Feb 3 | Feb 4 | S | 333 | $12.90 | Sale −$4,296 | 1,629,254 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 3 | Feb 4 | S | 10,204 | $12.26 | Sale −$125,101 | 184,410 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 3 | Feb 4 | S | 113 | $12.90 | Sale −$1,458 | 184,297 | No | Form 4 |
| Crystal AdamPresident, R&D | Feb 2 | Feb 4 | A | 47,460 | $0.00 | $0 | 205,670 | No | Form 4 |
| Crystal AdamPresident, R&D | Feb 2 | Feb 4 | A · derivative | 284,760 | $11.94 | $3,400,034 | 284,760 | No | Form 4 |
| Weber BarbaraDirector, Executive Chair | Feb 2 | Feb 4 | A | 37,522 | $0.00 | $0 | 1,659,773 | No | Form 4 |
| Weber BarbaraDirector, Executive Chair | Feb 2 | Feb 4 | A · derivative | 222,132 | $11.94 | $2,652,256 | 222,132 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 2 | Feb 4 | A | 44,330 | $0.00 | $0 | 194,614 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 2 | Feb 4 | A · derivative | 265,980 | $11.94 | $3,175,801 | 265,980 | No | Form 4 |
| Peters MaltePresident & CEO | Jan 8 | Jan 12 | A | 350,000 | $0.00 | $0 | 367,500 | No | Form 4 |
| Peters MaltePresident & CEO | Jan 8 | Jan 12 | A · derivative | 1,650,000 | $11.06 | $18,249,000 | 1,650,000 | No | Form 4 |
| Lee Sung | Jan 2 | Jan 6 | A | 10,000 | $0.00 | $0 | 10,000 | No | Form 4 |
| Lee Sung | Jan 2 | Jan 6 | A · derivative | 60,000 | $8.93 | $535,800 | 60,000 | No | Form 4 |
| Peters Malte | Nov 3, 2025 | Nov 4, 2025 | A · derivative | 150,000 | $8.01 | $1,201,500 | 150,000 | No | Form 4 |
| Trv Gp IV, LLC | Oct 23, 2025 | Oct 27, 2025 | S | 477,401 | $10.15 | Sale −$4,845,620 | 13,386,574 | No | Form 4 |
| Trv Gp IV, LLC | Sep 25, 2025 | Sep 29, 2025 | S | 500,000 | $8.02 | Sale −$4,010,000 | 13,863,975 | No | Form 4 |
| Trv Gp IV, LLC | Sep 16, 2025 | Sep 17, 2025 | S | 363,541 | $7.04 | Sale −$2,559,329 | 14,363,975 | No | Form 4 |
| Trv Gp IV, LLC | Sep 8, 2025 | Sep 9, 2025 | S | 86,459 | $7.04 | Sale −$608,671 | 14,727,516 | No | Form 4 |
| Trv Gp IV, LLC | Sep 5, 2025 | Sep 9, 2025 | S | 642,906 | $7.00 | Sale −$4,500,342 | 14,813,975 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Aug 22, 2025 | Aug 26, 2025 | S | 302,194 | $7.00 | Sale −$2,115,358 | 15,456,881 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Aug 19, 2025 | Aug 21, 2025 | S | 1,100,000 | $7.01 | Sale −$7,711,000 | 15,759,075 | No | Form 4 |
| Borisy Alexis | Jun 5, 2025 | Jun 9, 2025 | A | 6,250 | $0.00 | $0 | 17,500 | No | Form 4 |
| Borisy Alexis | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 37,500 | $3.51 | $131,625 | 37,500 | No | Form 4 |
| Ketchum John B | Jun 5, 2025 | Jun 9, 2025 | A | 6,250 | $0.00 | $0 | 20,937 | No | Form 4 |
| Ketchum John B | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 37,500 | $3.51 | $131,625 | 37,500 | No | Form 4 |
| Rothenberg Mace | Jun 5, 2025 | Jun 9, 2025 | A | 6,250 | $0.00 | $0 | 37,500 | No | Form 4 |
| Rothenberg Mace | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 37,500 | $3.51 | $131,625 | 37,500 | No | Form 4 |
| Calhoun Lesley Ann | Jun 5, 2025 | Jun 9, 2025 | A | 6,250 | $0.00 | $0 | 12,500 | No | Form 4 |
| Calhoun Lesley Ann | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 37,500 | $3.51 | $131,625 | 37,500 | No | Form 4 |
| Peters Malte | Jun 5, 2025 | Jun 9, 2025 | A | 6,250 | $0.00 | $0 | 17,500 | No | Form 4 |
| Peters Malte | Jun 5, 2025 | Jun 9, 2025 | A · derivative | 37,500 | $3.51 | $131,625 | 37,500 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 5, 2025 | Feb 6, 2025 | S | 9,013 | $3.16 | Sale −$28,481 | 1,622,251 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 5, 2025 | Feb 6, 2025 | S | 6,851 | $3.16 | Sale −$21,649 | 158,210 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 5, 2025 | Feb 6, 2025 | S | 3,948 | $3.16 | Sale −$12,476 | 150,284 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 5, 2025 | Feb 6, 2025 | S | 2,556 | $3.16 | Sale −$8,077 | 66,014 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 4, 2025 | Feb 6, 2025 | S | 9,778 | $2.99 | Sale −$29,236 | 1,631,264 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 4, 2025 | Feb 6, 2025 | S | 7,432 | $2.99 | Sale −$22,222 | 165,061 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 4, 2025 | Feb 6, 2025 | S | 4,284 | $2.99 | Sale −$12,809 | 154,232 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 4, 2025 | Feb 6, 2025 | S | 2,774 | $2.99 | Sale −$8,294 | 68,570 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 3, 2025 | Feb 5, 2025 | A | 27,363 | $0.00 | $0 | 71,344 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 164,175 | $2.91 | $477,749 | 164,175 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 3, 2025 | Feb 5, 2025 | A | 105,875 | $0.00 | $0 | 1,641,042 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 635,250 | $2.91 | $1,848,578 | 635,250 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 3, 2025 | Feb 5, 2025 | A | 53,015 | $0.00 | $0 | 172,493 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 318,090 | $2.91 | $925,642 | 318,090 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 3, 2025 | Feb 5, 2025 | A | 26,119 | $0.00 | $0 | 158,516 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 3, 2025 | Feb 5, 2025 | A · derivative | 156,713 | $2.91 | $456,035 | 156,713 | No | Form 4 |
| Rothenberg Mace | Nov 18, 2024 | Nov 18, 2024 | P | 10,000 | $3.78 | Purchase +$37,800 | 31,250 | No | Form 4 |
| Rothenberg Mace | Nov 14, 2024 | Nov 18, 2024 | P | 10,000 | $3.62 | Purchase +$36,200 | 21,250 | No | Form 4 |
| EcoR1 Capital, LLC | Nov 7, 2024 | Nov 8, 2024 | S | 62,318 | $3.29 | Sale −$205,026 | 11,773,860 | No | Form 4 |
| EcoR1 Capital, LLC | Nov 7, 2024 | Nov 8, 2024 | S | 1,143,124 | $2.92 | Sale −$3,337,922 | 10,630,736 | No | Form 4 |
| EcoR1 Capital, LLC | Nov 6, 2024 | Nov 8, 2024 | S | 1,494,558 | $3.28 | Sale −$4,902,150 | 11,836,178 | No | Form 4 |
| Boxer Capital Management, LLC | Nov 6, 2024 | Nov 7, 2024 | S | 3,080,000 | $3.14 | Sale −$9,671,200 | 3,610,642 | No | Form 4 |
| Boxer Capital Management, LLC | Oct 25, 2024 | Oct 28, 2024 | S | 633,000 | $6.87 | Sale −$4,348,710 | 6,690,642 | No | Form 4 |
| Boxer Capital Management, LLC | Oct 22, 2024 | Oct 23, 2024 | S | 250,000 | $6.78 | Sale −$1,695,000 | 7,323,642 | No | Form 4 |
| Boxer Capital Management, LLC | Oct 21, 2024 | Oct 23, 2024 | S | 625,000 | $7.05 | Sale −$4,406,250 | 7,573,642 | No | Form 4 |
| Trv Gp IV, LLC | Sep 13, 2024 | Sep 17, 2024 | S | 67,400 | $10.53 | Sale −$709,722 | 16,859,075 | No | Form 4 |
| Trv Gp IV, LLC | Sep 5, 2024 | Sep 9, 2024 | S | 75,000 | $11.56 | Sale −$867,000 | 16,926,475 | No | Form 4 |
| Davis Aaron I. | Sep 3, 2024 | Sep 5, 2024 | J · derivative | 65,000 | $10.93 | $710,450 | 65,000 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Aug 30, 2024 | Sep 4, 2024 | S | 175,000 | $11.60 | Sale −$2,030,000 | 17,001,475 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Aug 27, 2024 | Aug 29, 2024 | S | 25,000 | $11.55 | Sale −$288,750 | 17,176,475 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Aug 19, 2024 | Aug 20, 2024 | S | 150,000 | $10.09 | Sale −$1,513,500 | 17,201,475 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Aug 16, 2024 | Aug 20, 2024 | S | 135,000 | $9.79 | Sale −$1,321,650 | 17,351,475 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Aug 1, 2024 | Aug 1, 2024 | S | 40,000 | $9.80 | Sale −$392,000 | 17,486,475 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Jul 31, 2024 | Aug 1, 2024 | S | 100,000 | $9.93 | Sale −$993,000 | 17,526,475 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Jul 30, 2024 | Aug 1, 2024 | S | 95,000 | $9.80 | Sale −$931,000 | 17,626,475 | No | Form 4 |
| Trv Gp IV, LLC | Jul 26, 2024 | Jul 30, 2024 | S | 50,000 | $9.84 | Sale −$492,000 | 17,721,475 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Jul 25, 2024 | Jul 26, 2024 | S | 100,599 | $9.87 | Sale −$992,912 | 17,771,475 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Jul 24, 2024 | Jul 26, 2024 | S | 200,000 | $9.82 | Sale −$1,964,000 | 17,872,074 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Jul 23, 2024 | Jul 24, 2024 | S | 125,000 | $9.79 | Sale −$1,223,750 | 18,072,074 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Jul 22, 2024 | Jul 24, 2024 | S | 262,740 | $9.78 | Sale −$2,569,597 | 18,197,074 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Jul 18, 2024 | Jul 22, 2024 | S | 191,490 | $9.81 | Sale −$1,878,517 | 18,459,814 | No | Form 4 |
| Third Rock Ventures GP IV, L.P. | Jul 17, 2024 | Jul 18, 2024 | S | 550,171 | $9.79 | Sale −$5,386,174 | 18,651,304 | No | Form 4 |
| MVA Investors, LLC | Jul 2, 2024 | Jul 2, 2024 | S | 95,000 | $8.68 | Sale −$824,600 | 108,793 | No | Form 4 |
| MVA Investors, LLC | Jul 1, 2024 | Jul 2, 2024 | S | 110,731 | $8.87 | Sale −$982,184 | 203,793 | No | Form 4 |
| MVA Investors, LLC | Jun 28, 2024 | Jul 2, 2024 | S | 29,000 | $8.57 | Sale −$248,530 | 314,524 | No | Form 4 |
| MVA Investors, LLC | Jun 7, 2024 | Jun 7, 2024 | S | 77,000 | $6.88 | Sale −$529,760 | 343,524 | No | Form 4 |
| MVA Investors, LLC | Jun 6, 2024 | Jun 7, 2024 | S | 63,000 | $7.24 | Sale −$456,120 | 420,524 | No | Form 4 |
| Borisy Alexis | Jun 5, 2024 | Jun 7, 2024 | A | 6,250 | $0.00 | $0 | 11,250 | No | Form 4 |
| Borisy Alexis | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 37,500 | $7.41 | $277,875 | 37,500 | No | Form 4 |
| Ketchum John B | Jun 5, 2024 | Jun 7, 2024 | A | 4,687 | $0.00 | $0 | 14,687 | No | Form 4 |
| Ketchum John B | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 28,125 | $7.41 | $208,406 | 28,125 | No | Form 4 |
| Calhoun Lesley Ann | Jun 5, 2024 | Jun 7, 2024 | A | 6,250 | $0.00 | $0 | 11,250 | Yes | Form 4 |
| Calhoun Lesley Ann | Jun 5, 2024 | Jun 7, 2024 | S | 5,000 | $7.21 | Sale −$36,050 | 6,250 | Yes | Form 4 |
| Calhoun Lesley Ann | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 37,500 | $7.41 | $277,875 | 37,500 | Yes | Form 4 |
| Rothenberg Mace | Jun 5, 2024 | Jun 7, 2024 | A | 6,250 | $0.00 | $0 | 11,250 | No | Form 4 |
| Rothenberg Mace | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 37,500 | $7.41 | $277,875 | 37,500 | No | Form 4 |
| Peters Malte | Jun 5, 2024 | Jun 7, 2024 | A | 6,250 | $0.00 | $0 | 11,250 | No | Form 4 |
| Peters Malte | Jun 5, 2024 | Jun 7, 2024 | A · derivative | 37,500 | $7.41 | $277,875 | 37,500 | No | Form 4 |
| MVA Investors, LLC | May 3, 2024 | May 3, 2024 | S | 60,000 | $7.61 | Sale −$456,600 | 483,524 | No | Form 4 |
| MVA Investors, LLC | May 2, 2024 | May 3, 2024 | S | 75,000 | $7.56 | Sale −$567,000 | 543,524 | No | Form 4 |
| MVA Investors, LLC | May 1, 2024 | May 3, 2024 | S | 75,000 | $7.43 | Sale −$557,250 | 618,524 | No | Form 4 |
| Third Rock Ventures IV, L.P. | Feb 20, 2024 | Feb 21, 2024 | S | 162,500 | $12.00 | Sale −$1,950,000 | 19,201,475 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 7, 2024 | Feb 8, 2024 | S | 4,083 | $12.62 | Sale −$51,527 | 119,478 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 7, 2024 | Feb 8, 2024 | S | 1,817 | $12.62 | Sale −$22,931 | 132,397 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 7, 2024 | Feb 8, 2024 | S | 1,354 | $12.62 | Sale −$17,087 | 43,981 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 7, 2024 | Feb 8, 2024 | S | 4,457 | $12.62 | Sale −$56,247 | 1,535,167 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 6, 2024 | Feb 8, 2024 | S | 4,288 | $12.56 | Sale −$53,857 | 123,561 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 6, 2024 | Feb 8, 2024 | S | 1,908 | $12.56 | Sale −$23,964 | 134,214 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 6, 2024 | Feb 8, 2024 | S | 1,422 | $12.56 | Sale −$17,860 | 45,335 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 6, 2024 | Feb 8, 2024 | S | 4,681 | $12.56 | Sale −$58,793 | 1,539,624 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 1, 2024 | Feb 5, 2024 | A | 22,859 | $0.00 | $0 | 22,859 | No | Form 4 |
| Barry DouglasGeneral Counsel | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 137,156 | $12.28 | $1,684,276 | 137,156 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | A | 87,168 | $0.00 | $0 | 87,168 | No | Form 4 |
| Weber BarbaraChief Executive Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 523,012 | $12.28 | $6,422,587 | 523,012 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 1, 2024 | Feb 5, 2024 | A | 46,599 | $0.00 | $0 | 46,599 | No | Form 4 |
| Crystal AdamSee Remarks | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 279,593 | $12.28 | $3,433,402 | 279,593 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 1, 2024 | Feb 5, 2024 | A | 39,413 | $0.00 | $0 | 39,413 | No | Form 4 |
| Beckman DaniellaChief Financial Officer | Feb 1, 2024 | Feb 5, 2024 | A · derivative | 236,475 | $12.28 | $2,903,913 | 236,475 | No | Form 4 |
| Crystal AdamSee Remarks | Nov 1, 2023 | Nov 2, 2023 | S | 7,507 | $8.39 | Sale −$62,984 | 81,250 | No | Form 4 |
| Davis Aaron I. | Oct 16, 2023 | Oct 17, 20234/A | P | 500,000 | $6.84 | Purchase +$3,420,000 | 8,198,642 | No | Form 4/A |
| Davis Aaron I. | Oct 13, 2023 | Oct 17, 20234/A | P | 750,000 | $7.07 | Purchase +$5,302,500 | 7,698,642 | No | Form 4/A |
| MVA Investors, LLC | Oct 9, 2023 | Oct 11, 2023 | S | 50,000 | $9.91 | Sale −$495,500 | 693,524 | No | Form 4 |
| MVA Investors, LLC | Oct 9, 2023 | Oct 11, 2023 | S | 175,000 | $9.97 | Sale −$1,744,750 | 6,948,642 | No | Form 4 |
| Davis Aaron I. | Aug 11, 2023 | Oct 11, 20234/A | A | 475,000 | $5.15 | $2,446,250 | 743,542 | No | Form 4/A |
| Davis Aaron I. | Aug 11, 2023 | Oct 11, 20234/A | A · derivative | 2,340,579 | $5.15 | $12,053,982 | 2,340,579 | No | Form 4/A |